PATTERNS OF NEURONAL DEGENERATION IN THE MOTOR CORTEX OF AMYOTROPHIC-LATERAL-SCLEROSIS PATIENTS

被引:182
|
作者
NIHEI, K
MCKEE, AC
KOWALL, NW
机构
[1] MASSACHUSETTS GEN HOSP,NEUROL SERV,BOSTON,MA 02114
[2] MASSACHUSETTS GEN HOSP,DEPT NEUROPATHOL,BOSTON,MA 02114
[3] YAMAGATA UNIV,DEPT INTERNAL MED 3,YAMAGATA 99023,JAPAN
[4] BOSTON UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02118
[5] BOSTON UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02118
[6] BEDFORD VA MED CTR,CTR GERIATR RES EDUC CLIN,BEDFORD,MA 01730
关键词
AMYOTROPHIC LATERAL SCLEROSIS; MOTOR CORTEX; CYTOSKELETAL PROTEINS; PARVALBUMIN; NADPH-DIAPHORASE;
D O I
10.1007/BF00454899
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We examined patterns of neuronal degeneration in the motor cortex of amyotrophic lateral sclerosis (ALS) patients using traditional cell stains and several histochemical markers including neurofilament, parvalbumin, NADPH-diaphorase, ubiquitin. Alz-50 and tau. Three grades of ALS (mild, moderate, severe) were defined based on the extent of Betz cell depletion. Non-phosphorylated neurofilament immunoreactive cortical pyramidal neurons and non-pyramidal parvalbumin local circuit neurons were significantly depleted in all grades of ALS. In contrast, NADPH-diaphorase neurons and Alz-50-positive neurons were quantitatively preserved despite reduced NADPH-diaphorase cellular staining and dendritic pruning. The density of ubiquitin-positive structures in the middle and deep layers of the motor cortex was increased in all cases. Axonal tau immunoreactivity was not altered. These histochemical results suggest that cortical degeneration in ALS is distinctive from other neurodegenerative diseases affecting cerebral cortex. Unlike Huntington's disease, both pyramidal and local cortical neurons are affected in ALS; unlike Alzheimer's disease, alteration of the neuronal cytoskeleton is not prominent. The unique pattern of neuronal degeneration found in ALS motor cortex is consistent with non-N-methyl-D-aspartate glutamate receptor-mediated cytotoxicity.
引用
收藏
页码:55 / 64
页数:10
相关论文
共 50 条
  • [21] IMMUNOSUPPRESSIVE TREATMENT OF PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS
    WERDELIN, L
    BOYSEN, G
    JENSEN, TS
    MOGENSEN, P
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 1990, 82 (02): : 132 - 134
  • [22] EXCITOTOXIC NEURONAL CELL-DEATH IN AMYOTROPHIC-LATERAL-SCLEROSIS
    APPEL, SH
    [J]. TRENDS IN NEUROSCIENCES, 1993, 16 (01) : 3 - 5
  • [23] REDUCED ISOTOPE UPTAKE RESTRICTED TO THE MOTOR AREA IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS
    ABE, K
    YORIFUJI, S
    NISHIKAWA, Y
    [J]. NEURORADIOLOGY, 1993, 35 (06) : 410 - 411
  • [24] Excitability of the motor cortex in amyotrophic lateral sclerosis
    Eisen, A
    Nakajima, M
    Stewart, H
    Weber, M
    [J]. CLINICAL NEUROPHYSIOLOGY: FROM RECEPTORS TO PERCEPTION, 1999, 50 : 175 - 182
  • [25] Motor cortex hyperexcitability in amyotrophic lateral sclerosis
    Bolokadze, L. F.
    Fedotova, I. F.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 250 - 250
  • [26] A VARIETY OF AMYOTROPHIC-LATERAL-SCLEROSIS
    PROTAS, II
    DRAKIN, SA
    NEDZVED, MK
    MILKAMANOVICH, EK
    [J]. ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 1992, 92 (02): : 25 - 30
  • [27] NEUROPHARMACOLOGY OF AMYOTROPHIC-LATERAL-SCLEROSIS
    ASKMARK, H
    AQUILONIUS, SM
    GILLBERG, PG
    [J]. PROGRESS IN BRAIN RESEARCH, 1990, 84 : 371 - 380
  • [28] AMYOTROPHIC-LATERAL-SCLEROSIS AND PREGNANCY
    VINCENT, O
    RODRIGUEZITHURRALDE, D
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1995, 129 : 42 - 43
  • [29] ATYPICAL AMYOTROPHIC-LATERAL-SCLEROSIS
    BENHAMIDA, M
    HENTATI, F
    [J]. PATHOGENESIS AND THERAPY OF AMYOTROPHIC LATERAL SCLEROSIS, 1995, 68 : 153 - 155
  • [30] AMYOTROPHIC-LATERAL-SCLEROSIS AND AUTOIMMUNITY
    ROWLAND, LP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (24): : 1752 - 1753